絞り込み

16555

広告

The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.

著者 Yamashita H , Kanamori A , Kano C , Hashimura H , Matsumoto K , Tsujimae M , Yoshizaki T , Momose K , Obata D , Eguchi T , Fujita M , Okada A
Digestion.2017 Jun 30 ; 96(1):52-59.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (1,297view , 0users)

Full Text Sources

Miscellaneous

The effects of vonoprazan and proton pump inhibitors (PPIs) in patients with reflux esophagitis (RE) have not yet been compared using multichannel intraluminal impedance-pH (MII-pH).
PMID: 28662503 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード